Publications by authors named "M Ghesani"
Peptide receptor radionuclide therapy (PRRT) is used for the management of neuroendocrine tumors (NETs) not responsive to somatostatin analogs. In this case series, we report two patients with pancreatic vasoactive intestinal peptide (VIP)-secreting NETs (VIPomas) not responsive to any other therapies who achieved symptomatic control and a significant decrease in serum VIP levels with PRRT during their hospital stay. Two patients with VIPomas were admitted to the hospital with multiple prior hospital admissions after going through multiple lines of therapy.
View Article and Find Full Text PDFBackground: Enzalutamide is an antiandrogen drug used prior to lutetium-177 prostate specific membrane antigen (Lu-PSMA) radioligand therapy and has shown promising results for upregulating the PSMA expression on prostate cancer cells. In this study, we aim to compare prostate specific antigen (PSA) level changes in prostate cancer patients who received enzalutamide to those who did not.
Methods: Prostate cancer patients who underwent Lu-PSMA between 2021 and 2023 were retrospectively included.
The main aim of this study was to evaluate the current state of bibliometric and altmetric research output of [Ac]Ac-Prostate specific membrane antigen (PSMA) and its implications for prostate cancer (PC). Both PubMed and Scopus digital libraries were systematically explored to retrieve relevant data on the topic of interest. The study of various bibliometric and altmetric indices was facilitated through the use of Microsoft Excel, Stata (Version 17.
View Article and Find Full Text PDFArticle Synopsis
- The revised practice parameter is designed for licensed physicians using radiopharmaceuticals, outlining necessary written directives under federal regulations (NRC 10 CFR 35.300).
- Developed by key organizations in radiation and nuclear medicine, the parameter follows established processes for creating clinical guidelines.
- It details the roles of healthcare professionals involved in radiopharmaceutical therapy and provides insights into different types of therapeutic agents, their applications, and the competencies required for safe delivery.